HAL (France)open access
Amélioration de l’immunothérapie à base de Natural Killer (NK) : combinaison avec des anticorps monoclonaux modifiés
Chimeric antigen receptors CAR, Immunotherapies, Oncology, Oncologie, 0, NK cells, Anticorps monoclonaux, 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 262170
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.